The interleukin-15/interleukin-15 receptor system as a model for juxtacrine and reverse signaling

BioEssays

Volumn 28, Issue 4, 2006, Pages 362-377

  Bulfone Paus, Silvia ^a   Bulanova, Elena ^a   Budagian, Vadim ^a   Paus, Ralf ^b  

^a RESEARCH CENTER BORSTEL   (Germany)

^b UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 15; INTERLEUKIN 15 RECEPTOR; JANUS KINASE 1; JANUS KINASE 3; MESSENGER RNA; PROTEIN KINASE SYK; STAT3 PROTEIN; STAT5 PROTEIN; STAT6 PROTEIN; TUMOR NECROSIS FACTOR ALPHA CONVERTING ENZYME;

CELL ADHESION; CELL MIGRATION; HUMAN; IMMUNOHISTOLOGY; IMMUNOPATHOLOGY; IMMUNOREACTIVITY; INFECTION; NONHUMAN; PHENOTYPE; PLEIOTROPY; PROTEIN PHOSPHORYLATION; REVIEW; SIGNAL PROCESSING; T LYMPHOCYTE; UPREGULATION;

ANIMALS; HUMANS; INTERLEUKIN-15; MODELS, BIOLOGICAL; PARACRINE COMMUNICATION; RECEPTORS, INTERLEUKIN-15; RECEPTORS, INTERLEUKIN-2; SIGNAL TRANSDUCTION;

EID: 33645833872     PISSN: 02659247     EISSN: None     Source Type: Journal    
DOI: 10.1002/bies.20380     Document Type: Review

References (102)

1. Eissner G, Kolch W, Schneurich P. 2004. Ligands working as receptors: reverse signaling by members of the TNF superfamily enhance the plasticity of the immune system. Cytokine Growth Factor Rev 15:353-366.
2. Murai KK, Pasquale EB. 2003. 'Eph'ective signaling: forward, reverse and crosstalk. J Cell Sci 116:2823-2832.
3. th Edition. Larsen PR, Kronenberg HM, Melmed S, Polonsky KS, editors. Philadelphia: W.B. Saunders Company, 2003.
4. Niki Y, Yamada H, Kikuchi T, Toyama Y, Matsumoto H, et al. 2004. Membrane-associated IL-1 contributes to chronic synovitis and cartilage destruction in human IL-1 alpha transgenic mice. J Immunol 172:577-584.
5. Werman A, Werman R, White R, Lee J-K, Werman B, et al. 2004. The precursor form of IL-1α is an intracrine proinflamatory activator of transcription. Proc Natl Acad Sci USA 101:2434-2439.
6. Eissner G, Kirchner H, Kolch W, Janosch P, Grell M, et al. 2000. Reverse signaling through transmembrane TNF confers resistance to lipopolysaccharide in human monocytes and macrophages. J Immunol 164:6193-6198.
7. Harashima S, Horiuchi T, Hatta N, Morita C, Higuchi M, et al. 2001. Outside-to-inside signal through the membrane TNF-α induces E-selectin (CD62E) expression on activated human CD4+ T cells. J Immunol 166:130-136.
8. Wiley SR, Goodwin RG, Smith CA. 1996. Reverse signaling via CD30 ligand. J Immunol 157:3635-3639.
9. Miyashita T, McIlraith MJ, Grammer AC, Miura Y, Attrep JF, et al. 1997. Bidirectional Regulation of Human B Cell Responses by CD40-CD40 Ligand Interactions. J Immunol 158:4620-4633.
10. Stuber E, Neurath M, Calderhead D, Fell HP, Strober W. 1995. Cross-linking of OX40 ligand, a member of the TNF/NGF cytokine family, induces proliferation and differentiation in murine splenic B cells. Immunity 2:507-521.
11. Langstein J, Michel J, Fritsche J, Kreutz M, Andereesen R, et al. 1998. CD137 (ILA/4-1BB), a member of the TNF receptor family, induces monocyte activation via bi-directional signaling. J Immunol 160:2488-2494.
12. Newell MK, Desbarats J. 1999. Fas ligand: receptor or ligand. Apoptosis 4:311-315.
13. van Essen D, Kikutani H, Gray D. 1995. CD40 ligand-transduced costimulation of T cells in the development of helper function. Nature 378:620-623.
14. Chen NJ, Huang MW, Hsien SL. 2001. Enhanced secretion of IFN-gamma by activated Th1 cells occurs via reverse signaling through TNF-related activation-induced cytokine. J Immunol 166:270-276.
15. Watts TH. 2005. TNF/TNFR family members in costimulation of T cell responses. Annu Rev Immunol 23:23-68.
16. Wan X, Zhang J, Luo H, Shi G, Kapnik E, et al. 2002. A TNF family member LIGHT transduces costimulatory signals into human T cells. J Immunol 169:6813-6821.
17. Watts AD, Hunt NH, Wanigasekara Y, Bloomfield G, Wallash D, et al. 1999. A casein kinase I motif present in the cytoplasmatic domain of members of the tumor necrosis factor ligand family is implicated in "reverse signaling". EMBO J 18:2119-2126.
18. Grabstein KH, Eisenman J, Shanebeck K, Rauch C, Srinivasan S, et al. 1994. Cloning of a T cell growth factor that interacts with the beta chain of the interleukin-2 receptor. Science 264:965-968.
19. Burton JD, Bamford RN, Peters C, Grant AJ, Kurys G, et al. 1994. A lymphokine, provisionally designated interleukin T and produced by a human adult T-cell leukemia line, stimulates T-cell proliferation and the induction of lymphokine-activated killer cells. Proc Natl Acad Sci USA 91:4935-4939.
20. Bazan JF. 1990. Structural design and molecular evolution of a cytokine receptor superfamily. Proc Natl Acad Sci USA 87:6934-6938.
21. Krause H, Jandrig B, Wenicke C, Bulfone-Paus S, Pohl T, et al. 1996. Genomic structure and chromosomal localization of the human interleukin 15 gene (IL-15). Cytokine 8:667-674.
22. Anderson DM, Johnson L, Glaccum MB, Copeland NG, Gilbert DJ, et al. 1995. Chromosomal assignment and genomic structure of IL-15. Genomics 25:701-706.
23. Briard D, Brouty-Boye D, Azzarone B, Jasmin C. 2002. Fibroblasts from human spleen regulate NK cell differentiation from blood CD34(+) progenitors via cell surface IL-15. J Immunol 168:4326-4632.
24. Ruckert R, Asadullah K, Seifert M, Budagian V, Arnold R, et al. 2000. Inhibition of keratinocyte apoptosis by IL-15: a new parameter in the pathogenesis of psoriasis? J Immunol 165:2240-2250.
25. Weiler M, Kachko L, Chaimovitz C, Van Kooten C, Douvdevani A. 2001. CD40 ligation enhances IL-15 production by tubular epithelial cells. J Am Soc Nephrol 12:80-87.
26. Doherty TM, Seder RA, Sher A. 1996. Induction and regulation of IL-15 expression in murine macrophages. J Immunol 156:735-741.
27. Mattel F, Schiavoni G, Belardelli F, Tough DF. 2001. IL-15 is expressed by dendritic cells in response to type I IFN, double-stranded RNA, or lipopolysacchride and promotes dendritic cell activation. J Immunol 167:1179-1187.
28. Musso T, Calosso L, Zucca M, Millesimo M, Ravarino D, et al. 1999. Human monocytes constitutively express membrane-bound, biologically active, and interferon-γ-upregulated interleukin-15. Blood 93: 3531-3539.
29. Satoh J, Kurohara K, Yukitake M, Kuroda Y. 1998. Interleukin-15, a T-cell growth factor, is expressed in human neural cell lines and tissues. J Neurol Sci 155:170-177.
30. Quinn LS, Haugk KL, Grabstein KH. 1995. IL-15: a novel anabolic cytokine for skeletal muscle. Endocrinology 136:3669-3672.
31. Rückert R, Brandt K, Bulanova E, Mirghomizadeh F, Paus R, et al. 2003. Dendritic cell-derived IL-15 controls the induction of CD8 T cell immune responses. Eur J Immunol 33:3493-3503.
32. Kurys G, Tagaya Y, Bamford R, Hanover JA, Waldmann TA. 2000. The long signal peptide isoform and its alternative processing direct the intracellular trafficking of interleukin-15. J Biol Chem 275:30653-30659.
33. Gaggero A, Azzarone B, Andrei C, Mishal Z, Meazza R, et al. 1999. Differential intracellular trafficking, secretion and endosomal localization of two IL-15 isoforms. Eur J Immunol 29:1265-1274.
34. Meazza R, Verdiani S, Biassoni R, Coppolecchia M, Gaggero A, et al. 1996. Identification of a novel interleukin-15 (IL-15) transcript isoform generated by alternative splicing in human small cell lung cancer cell lines. Oncogene 12:255-262.
35. Prinz M, Hanisch UK, Kettenmann H, Kirchhoff F. 1998. Alternative splicing of mouse IL-15 is due to the use of internal splice site in exon 5. Brain Res Mol Brain Res 63:155-162.
36. Waldmann TA, Tagaya Y. 1999. The multifaceted regulation of interleukin-15 expression and the role of this cytokine in NK cell differentiation and host response to intracellular pathogens. Annu Rev Immunol 17:19-49.
37. Fehninger TA, Caligiuri MA. 2001. Interleukin 15: biology and relevance to human disease. Blood 97:14-32.
38. Bamford RN, Battiata AP, Burton JD, Sharma H, Waldmann TA. 1996. Interleukin (IL) 15/IL-T production by the adult T-cell leukemia cell line HuT-102 is associated with a human T-cell lymphotrophic virus type I R region/IL-15 fusion message that lacks many upstream AUGs that normally attenuate IL-15 mRNA translation. Proc Natl Acad Sci USA 93:2897-2902.
39. Bamford RN, DeFilippis AP, Azimi N, Kurys G, Waldmann TA. 1998. The 5′UTR, signal peptide and 3′ coding sequences of IL-15 participate in its multifaceted translational control. J Immunol 160: 4418-4426.
40. Onu A, Pohl T, Krause H, Bulfone-Paus S. 1997. Regulation of IL-15 secretion via the leader peptide of two IL-15 isoforms. J Immunol 158: 255-262.
41. Nishimura H, Fujimoto A, Tamura N, Yajima T, Wajjwalku W, et al. 2005. A novel autoregulatory mechanism for transcriptional activation of the IL-15 gene by a nonsecretable isoform of IL-15 generated by alternative splicing. FASEB J 19:19-28.
42. Pereno R, Giron-Michel J, Gaggero A, Cazes E, Meazza R, et al. 2000. IL-15/IL-15Rα intracellular trafficking in human melanoma cells and signal transduction through the IL-15Rα. Oncogene 19:5153-5162.
43. Neely GG, Robins SM, Amankwah EK, Epelman S, Wong H, et al. 2001. Lipopolysaccharide-stimulated or granulocyte-macrophage colony-stimulating factor-stimulated monocytes rapidly express biologically active IL-15 on their cell surface independent of new protein synthesis. J Immunol 167:5011-5017.
44. Robertson H, Kirby JA. 2003. Post-transplant renal tubulitis: the recruitment, differentiation and persistence of intra-epithelial T cells. Am J Transplant 3:3-10.
45. Carson WE, Giri JG, Lindemann MJ, Linett ML, Ahdieh M, et al. 1994. Interleukin (IL) 15 is a novel cytokine that activates human natural killer cells via components of IL-2 receptor. J Exp Med 180:1395-1403.
46. Giri JG, Ahdieh M, Eisenman J, Shanebeck K, Grabstein K, et al. 1994. Utilisation of beta and gamma chains of the IL-2 receptor by the novel cytokine IL-15. EMBO J 13:2822-2830.
47. Giri JG, Kumaki S, Ahdieh M, Friend DJ, Loomis A, et al. 1995. Identification and cloning of a novel IL-15 binding protein that is structurally related to the α chain of the IL-2 receptor. EMBO J 14: 3654-3653.
48. Anderson DM, Kumaki S, Ahdieh M, Bertles J, Tometsko M, et al. 1995. Functional characterization of the human interleukin-15 receptor α chain and close linkage of IL15RA and IL2RA genes. J Biol Chem 270:29862-29869.
49. Dubois S, Magrangeas F, Lehours P, Raher S, Bernard J, et al. 1999. Natural splicing of exon 2 of human interleukin-15 receptor α-chain mRNA in shortened form with a distinct pattern of expression. J Biol Chem 274:26978-26984.
50. Bulanova E, Budagian V, Orinska Z, Krause H, Paus R, et al. 2003. Mast cells express novel functional interleukin-15 receptor α isoforms. J Immunol 170:5045-5055.
51. Gunning P, Weinberger R. 1998. Isoforms sorting and the creation of intracellular compartments. Auu Rev Cell Develop Biol 14:339-372.
52. Bulfone-Paus S, Bulanova E, Pohl T, Budagian V, Dürkop H, et al. 1999. Death deflected: IL-15 inhibits TNFα-mediated apoptosis in fibroblasts by TRAF2 recruitment to the IL-ISRo chain. FASEB J 13:1575-1585.
53. Tagaya Y, Burton JD, Miyamoto Y, Waldmann TA. 1996. Identification of a novel receptor/signal transduction pathway for IL-15/T in mast cells. EMBO J 15:4928-4939.
54. Bulanova E, Budagian V, Pohl T, Krause H, Dürkop H, et al. 2001. The IL-15Rα chain signals through association with Syk in human B cells. J Immunol 170:5045-5055.
55. Budagian V, Bulanova E, Orinska Z, Thon L, Mamat U, et al. 2005. A promiscuous liaison between IL-15 receptor and Axl receptor tyrosine kinase in cells death control. EMBO J 24:4260-4270.
56. Ratthe C, Girard D. 2004. Interleukin-15 enhances human neutrophil phagocytosis by a Syk-dependent mechanism: importance of the IL-15Rα chain. J Leukoc Biol 76:162-168.
57. Johnston JA, Bacon CM, Finbloom DS, Rees RC, Kaplan D, et al. 1995. Tyrosine phosphorylation and activation of STAT 5, STAT 3, and Janus kinases by interleukin 2 and 15. Proc Natl Acad Sci USA 92:8705-8709.
58. Budagian V, Bulanova E, Orinska Z, Ludwig A, Rose-John S, et al. 2004. Natural soluble interleukin-15Rα is generated by cleavage that involves the tumor necrosis factor-α-converting enzyme (TACE/ADAM 17). J BiOl Chem 279:40368-40375.
59. Mortier E, Bernard J, Plet A, Jacques Y. 2004. Natural, proteolytic release of a soluble form of human IL-15 receptor α-chain that behaves as a specific, high affinity IL-15 antagonist. J Immunol 173:1681-1688.
60. Althoff K, Reddy P, Voltz N, Rose-John S, Müllberg J. 2000. Shedding of interleukin-6 receptor and tumor necrosis factor α. Eur J Biochem 267:2624-2631.
61. Blum H, Wolf M, Enssle K, Rollinghoff M, Gessner A. 1996. Two distinct stimulus-dependent pathways lead to production of soluble murine interleukin-4 receptor. J Immunol 157:1846-1853.
62. Dri P, Gasparini C, Menegazzi R, Cramer R, Alberi L, et al. 2000. TNF-induced shedding of TNF receptors in human polymorphonuclear leukocytes: role of the 55-kDa TNF receptor and involvement of a membrane-bound and non-matrix metalloproteinase. J Immunol 165: 2165-2172.
63. Hundhausen C, Misztela D, Berkhout TA, Broadway N, Saftig P, et al. 2003. The disintegrin-like metalloproteinase ADAM10 is involved in constitutive cleavage of CX3CL1 (fractalkine) and regulates CX3CL1-mediated cell-cell adhesion. Blood 102:1186-1195.
64. Ruchatz H, Leung BP, Wei XQ. McInnes IB, Liew FY. 1998. Soluble IL-15 receptor α-chain administration prevents murine collagen-induced arthritis: a role for IL-15 in development of antigen-induced immunopathology. J Immunol 160:5654-5660.
65. Smith SG, Bolton EM, Ruchatz H, Wei X, Liew FY, et al. 2000. Selective blockade of IL-15 by soluble IL-15 receptor α-chain enhances cardiac allograft survival. J Immunol 165:3444-3450.
66. Wei X, Orchardson M, Gracie JA, Leung BP, Gao B, et al. 2001. The Sushi domain of soluble IL-15 receptor alpha is essential for binding IL-15 and inhibiting inflammatory and allogenic responses in vitro and in vivo. J Immunol 167:277-282.
67. Rückert R, Brandt K, Braun A, Hoymann H-G, Herz U, et al. 2005. Blocking IL-15 prevents the induction of allergen-specific T cells and allergic inflammation in vivo. J Immunol 174:5507-5515.
68. Rose-John S. 2003. Interleukin-6 biology is coordinated by membrane bound and soluble receptors. Acta Biochem Pol 50:603-611.
69. Mortier E, Quemener A, Vusio P, Lorenzen I, Boublik Y, et al. 2006. Soluble IL-15Rα sushi as a selective and potent agonist of IL-15 action through IL-15Rβ/γ: hyper agonist IL-15-IL-15Rα fusion proteins. J Biol Chem 281:1612-1619.
70. Blobel CP. 2005. ADAMs: key components in EGFR signaling and development. Nat Rev Mol Cell Biol 6:32-43.
71. Waldmann TA, Dubois S, Tagaya Y. 2001. Contrasting roles of IL-2 and IL-15 in the life and death of lymphocytes: implication for immunotherapy. Immunity 14:105-110.
72. Bulfone-Paus S, Ungureanu D, Pohl T, Lindner G, Paus R, et al. 1997. Interleukin-15 protects from lethal apoptosis in vivo. Nat Med 3:1124-1128.
73. Lodolce JP, Burkett PR, Koka RM, Boone DL, Ma A. 2002. Regulation of lymphoid homeostasis by interleukin-15. Cytokine Growth Factor Rev 13:429-439.
74. Schluns KS, Stoklasek T, Lefrançois L. 2005. The role of interleukin-15 receptor α: trans-presentation, receptor component or both? Int J Biochem Cell Biol 37:1567-1571.
75. Maekawa Y, Tsukumo S, Okada H, Kishihara K, Yasutomo K. 2003. Breakdown of peripheral T-cell tolerance by chronic interleukin-15 elevation. Transplantation 76:415-420.
76. Tinhofer I, Marschitz I, Henn T, EgIe A, Greil R. 2000. Expression of functional interleukin-15 receptor and autocrine production of interleukin-15 as mechanisms of tumor propagation in multiple myeloma. Blood 95:610-618.
77. Musso T, Colosso L, Zucca M, Millesimo M, Piliti M, et al. 1998. Interleukin-15 activates proinflammatory and antimicrobial functions in polymorphonuclear cells. Infect Immunol 66:2640-2647.
78. Vasquez N, Walsh TJ, Friedman D, Chanock SJ, Lyman CA. 1998. Interleukin-15 augments superoxide production and microbicidal activity of human monocytes against Candida albicans. Infect Immun 66:145-150.
79. Kennedy MK, Glaccum M, Brown SN, Butz EA, Viney JL, et al. 2000. Reversible defects in natural killer and memory CDS T cell lineage in interleukin-15 deficient mice. J Exp Med 191:771-780.
80. Lodolce JP, Boone DL, Chai S, Swain RE, Dassopoulos T, et al. 1998. IL-15 receptor maintains lymphoid homeostasis by supporting lymphocyte homing and proliferation. Immunity 9:669-676.
81. Koka R, Burkett PR, Chien M, Chai S, Chan F, et al. 2003. Interleukin (IL)-15Rα-deficient natural killer cells survive in normal but not IL-15Rα-deficient mice. J Exp Med 197:977-984.
82. Becher TC, Wherry EJ, Boone D, Murali-Krishna K, Antia R, et al. 2002. Interleukin 15 is required for proliferation of virus-specific memory CDs T cells. J Exp Med 195:1541-1548.
83. Cassatella MA, McDonald PP. 2000. Interleukin-15 and its impact on neutrophil function. Curr Opin Hematol 7:174-177.
84. Agostini C, Trentin L, Facco M, Sancetta R, Cerutti A, et al. 1996. Role of IL-15, IL-2, and their receptors in the development of T cell alveolitis in pulmonary sarcoidosis. J Immunol 157:910-918.
85. Zambello R, Facco M, Trentin L, Sancetta R, Tassinari C, et al. 1997. Interleukin-15 triggers the proliferation and cytotoxicity of granular lymphocytes in patients with lymphoproliferative disease of granular lymphocytes. Blood 89:201-211.
86. Waldmann TA, Dubois S, Tagaya Y. 2001. IL-15Rα recycles and presents IL-15 in trans to neighboring cells. Immunity 14:105-110.
87. Park C-S, Yoon S-O, Armitage RJ, Choi YS. 2004. Follicular dendritic cells produce IL-15 that enhances germinal center B cello proliferation in membrane-bound form. J Immunol 173:6676-6683.
88. Koka R, Burkett P, Chien M, Chai S, Boone DL, et al. 2004. Murine dendritic cells require IL-15Ra to prime NK cells. J Immunol 173:3594-3598.
89. Kobayashi H, Dubois S, Sato N, Sabzevari H, Sakai Y, et al. 2005. Role of trans-cellular IL-15 presentation in the activation of NK cell-mediated killing, which leads to enhanced tumor immunosurveillance. Blood 105:721-727.
90. Sandau MM, Schluns KS, Lefrançois L, Jameson SC. 2004. Transpresentation of IL-15 by bone marrow-derived cells necessitates expression of IL-15 and IL-15Rα by the same cells. J Immunol 173:6537-6541.
91. Giron-Michel J, Guiliani M, Fogli M, Brouty-Boye D, Ferrini S, et al. 2005. Membrane-bound and soluble IL-15/IL-15Rα complexes display differential signaling and functions on human haematopoietic progenitors. Blood 106:2302-2310.
92. Budagian V, Bulanova E, Orinska Z, Pohl T, Borden EC, et al. 2004. Reverse signaling through membrane-bound interleukin-15. J Biol Chem 279:42192-42201.
93. Neely GG, Epelman S, Ma LL, Colaruso P, Hofler CJ, et al. 2004. Monocytes surface-bound IL-15 can function as an activating receptor and participate in reverse signaling. J Immunol 172:4225-4234.
94. Bernard J, Harb C, Mortier E, Quemener A, Meloen RH, et al. 2004. Identification of an interleukin-15Ralpha receptor-binding site on human interleukin-15. J Biol Chem 279:24313-24322.
95. McInnes IB, Gracie JA, Harnett M, Harnett W, Liew FY. 2003. New strategies to control inflammatory synovitis: interleukin 15 and beyond. Ann Rheum Dis 62:51-54.
96. McInnes IB, al-Mughales J, Field M, Leung BP, Huang FP, et al. 1996. The role of IL-15 in T-cell migration and activation in rheumatoid arthritis. Nat Med 2:175-182.
97. Liu Z, Geboes K, Colpaert S, D'Haens GR, Rutgeerts P, et al. 2000. IL-15 is highly expressed in inflammatory bowel disease and regulates local T cell-dependent cytokine production. J Immunol 164:3608-3615.
98. Kuczynski S, Winiarska H, Abramczyk M, Szczawinska K, Wierusz-Wysocka B, et al. 2005. IL-15 is elevated in serum patients with type 1 diabetes mellitus. Diabetes Res Clin Pract 69:231-236.
99. Aringer M, Stummvoll GH, Steiner G, Koller M, Steiner CW, et al. 2001. Serum interleukin-15 is elevated in systemic lupus erythematosus. Rheumatology (Oxford) 40:876-881.
100. Baranda L, de la Fuente H, Layseca-Espinosa E, Portales-Perez D, Nino-Moreno P, et al. 2005. IL-15 and IL-15R in leucocytes from patients with systemic lupus erythematosus. Rheumatology 44:1507-1513.
101. Kim YS, Maslinski W, Zheng XX, Stevens AC, Li XC, et al. 1998. Targeting the IL-15 receptor with an antagonist IL-15 mutant/Fc gamma2a protein blocks delayed-type hypersensitivity. J Immunol 160:5742-5748.
102. Waldmann TA. 2004. Targeting the interleukin-15/interleukin-15 receptor system in inflammatory autoimmune diseases. Arthritis Res Ther 6: 174-177.